America’s New Drug Dealers Have Moved from Street Corners to the Internet – and the FDA is Letting Them
(Peter Pitts, President and Co-founder of the Center for Medicine in the Public Interest )
- Consumers purchasing retatrutide online may think they are buying a safe, clinically tested weight-loss drug. They are not. Medical spas and online sellers have built a booming black market around an unapproved investigational drug – exploiting polished websites and professional packaging to sell illegal drugs to unsuspecting Americans. What is especially concerning about today’s version of this deception is how FDA is doing nothing to stop it, allowing this black market to turn into a digital-age Wild West.
Retatrutide is an investigational molecule currently being studied in clinical trials for the treatment of obesity. It has not yet received approval from the Food and Drug Administration (FDA) and cannot be lawfully sold. That is not an opinion. That is the law. And yet sellers are aggressively marketing it as equivalent to – or even superior to – FDA-approved therapies already on the market.
Illicit retatrutide is being sourced from unregistered foreign manufacturers with no assurance of sterility, potency, or ingredient authenticity. When something goes wrong, distributors face no accountability and no obligation to report it. Consumers have no meaningful way of knowing what they are actually injecting – and the consequences are already showing up in hospitals and poison centers across the country.
Documented reports describe hospitalizations for acute kidney damage and severe gastrointestinal distress. One 42-year-old woman was rushed to the emergency room after experiencing severe symptoms from black market “retatrutide” she purchased online. Poison center reports have surged – with hundreds of reports in the first four months of 2026.
FDA’s response to this explosion of illegal drugs – a handful of warning letters with no follow up – amounts to less than a slap on the wrist. Warning letters do not shut down black markets. Arrests and seizures do.
The deeper threat is institutional – every day this market operates without aggressive enforcement, it becomes more entrenched, profitable, and normalized. The message that FDA is sending to these criminal sellers is that there is no cop on the beat. When they turn to even more dangerous and brazen schemes to sell these illegal drugs, it will be that much harder for FDA to put a stop to them when it finally decides to act. That erosion of institutional credibility has consequences that outlast any single drug.
Clinical trials exist because consumer demand is not a substitute for scientific evidence. Allowing investigational peptides to become internet lifestyle products before FDA review and approval is not the democratization of medicine, but the degradation of it.
The FDA must take aggressive steps to shut down this market and must coordinate with the Department of Justice, Customs and Border Protection, and the Federal Trade Commission to pursue seizures, injunctions, and criminal referrals against the sellers and platforms fueling this illegal market. The longer regulators hesitate, the harder this black market becomes to unwind. The FDA must act now – before the window closes to rein in this new frontier for illegal drugs in the digital age.
- If you own a small business, you're likely focused on growing revenue, serving customers, supporting employees, and staying competitive. But when you think about the business you've worked so hard to build, how do you envision it supporting you and your family’s financial future?
- Many parents think kindergarten readiness starts with learning letters, numbers and how to write a name. Those skills matter, but educators know that the social-emotional and executive function skills children develop before they ever walk into elementary school play an important role in kindergarten readiness.
- Dr. Koo, EVP and CMO at Prostate Cancer Foundation, and Bill, who is living with prostate cancer, answer some frequently asked questions about PSMA testing. Talk to your doctor and visit 
- Vanessa had a plan. As a travel nurse from Memphis, Tennessee, she was working across the country, building her career and saving up to buy a home. She had mapped out her next steps and was looking ahead to a future she worked hard to create. 

- It's no secret that kids today are struggling with mental health. Heightened academic pressure, the stress of growing up, family dynamics and lack of social connection all play a role, alongside the overuse of phones and devices.
- Over the past few months, you may have come across advertisements online or on social media for a new weight loss drug called retatrutide, also commonly referred to as “Reta” or “GLP-3.” Despite savvy marketing and “personal testimonials,” there is something critical consumers need to know: retatrutide is not FDA approved for human-use, and the companies selling it are operating illegally through unregulated channels.
- As families prepare for a new school year,
- Proposed rule changes at the Office of Management and Budget (OMB) could weaken the research enterprise that underpins American technology leadership, according to experts at the Special Competitive Studies Project (SCSP), a nonprofit, nonpartisan initiative that makes recommendations to strengthen America's long-term competitiveness in emerging technologies.
- For individuals with developmental disabilities and their families, fitness can mean much more than getting stronger or improving endurance. The right approach to movement can help people develop confidence, establish healthier routines, build physical skills and work toward greater independence.
